TITLE

tazarotene

PUB. DATE
January 2002
SOURCE
Royal Society of Medicine: Medicines;2002, p523
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
The article presents information on tazarotene which is chemically a derivative of retinol or vitamin A. This drug can be used to treat mild to moderate plaque psoriasis. Administration is by topical application. It should not be used in pregnancy or breast-feeding. Patients should wash hands immediately after use, and avoid contact with eyes, face, hair-covered scalp, eczematous or inflamed skin.
ACCESSION #
18961743

 

Related Articles

  • tacalcitol.  // Royal Society of Medicine: Medicines;2002, p522 

    The article presents information on tacalcitol which is an analogue of vitamin D. This drug is used as a skin treatment for plaque psoriasis. Administration is topical. There may be local irritation including itching, burning, erythema and tingling in the extremities. It should not be used in...

  • Treating Itch in Psoriasis. Dawn, Aerlyn; Yosipovitch, Gil // Dermatology Nursing;Jun2006, Vol. 18 Issue 3, p227 

    The article presents a study on the effective management and treatment of psoriatic itch. Patients with chronic pruritus often have difficulty sleeping, problems concentrating, lowered sex drive, and depression. The treatments recommended for psoriatic itch are tar products, topical...

  • Offer systemic therapy as first-line defense. Rutledge, Barbara J. // Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS16 

    Evaluates the efficacy of alefacept therapy as first-line defense for psoriasis. Impact of psoriasis on the quality of life of the patient; Number of people affected with the disease of the year; Treatment paradigms for psoriasis.

  • Efalizumab and etanercept cost-effective choices in psoriasis.  // PharmacoEconomics & Outcomes News;6/4/2005, Issue 479, p11 

    Discusses research being done on biologics for the treatment of psoriasis. Reference to a study by K. Ramos et al, published in April 2005 of the "Journal of Managed Care Pharmacy"; Analysis of the effectiveness of efalizumab and etanercept in treating the disease; Comparison between the...

  • New oral psoriasis agents show promise. Jesitus, John // Dermatology Times;Sep2004 Supplement, Vol. 25, pS13 

    Introduces different oral treatment for psoriasis. Side effects of the retinoid, an oral tazarotene; Acquisition of a new oral formulation of the drug BG-12 oral fumarate by Biogen; Discussion on the effects of oral pimecrolimus on psoriatic patients.

  • Easing trepidation about biologies. Kapes, Beth // Dermatology Times;Sep2004 Supplement, Vol. 25, pS27 

    Discusses the benefits offered by biologics for psoriasis treatment. Affirmation of David E. Cohen that the new biologic products offer advantages over existing medications; Presentation of new biologics that are approved for treating moderate to sever psoriasis and psoriatic arthritis;...

  • Physician says TNF-a antagonists very safe, overall. Guttman, Cheryl // Dermatology Times;Sep2004 Supplement, Vol. 25, pS33 

    Reports that TNF-a antagonists are safe for psoriatic patients. Presentation of several antagonists safe for psoriatic therapy; Discussion on the risks of serious infections and malignancies related to the immunosuppressive activity of the TNF-a antagonist; Effects on patients after treated with...

  • Study shows leading drugs' effectiveness against psoriasis. Jesitus, John // Dermatology Times;Sep2004 Supplement, Vol. 25, pS34 

    The article discusses the effectiveness of leading drugs against psoriasis. Statement of Craig L. Leonardi, associate dermatologist of St. Louis University in Missouri, on the effectiveness of Biogen's alefacept; Clarifications on the length of effectiveness of some drugs; Discussion on the...

  • new drugs for psoriasis might be lifesavers. Steinmehl, Eric; Martin, Adam // Health (Time Inc. Health);Mar2004, Vol. 18 Issue 2, p68 

    Provides information on biologics, a drug for treating psoriasis. Annual cost of the treatment; Percentage of people with psoriasis who consider committing suicide; Description of psoriasis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics